心脏术后血管紧张素II与肾素动力学关联研究
该回顾性研究纳入40例心脏术后高Δ-肾素水平(>3.7 µU/mL)且使用血管升压药的患者,比较使用血管紧张素II(AT-II)或仅用去甲肾上腺素对术后12小时肾素水平的影响。
要点
- 心脏术后高Δ-肾素患者中,AT-II与12小时肾素水平降低相关
- AT-II组去甲肾上腺素用量(中位1.33 mg)低于单用去甲肾上腺素组(3.25 mg)
- 需进一步研究证实AT-II在心脏手术中的应用价值
核心结论
- 在心脏术后低血压且高Δ-肾素水平的患者中,AT-II与术后12小时肾素血浆水平降低相关,并显著减少去甲肾上腺素使用;而单用去甲肾上腺素与肾素水平升高相关。
研究设计与样本
- 回顾性研究,2020年9月至2021年3月,纳入40例心脏手术患者,术后高Δ-肾素水平(>3.7 µU/mL)且使用血管升压药,分为AT-II组或单用去甲肾上腺素组。
主要发现
- 总体肾素血浆浓度中位数从基线44.3 µU/mL(Q1-Q3,14.6-155.5)升至体外循环后4小时的188.6 µU/mL(Q1-Q3,29.8-379.0)。
- 单用去甲肾上腺素组去甲肾上腺素中位剂量为3.25 mg(Q1-Q3,1.00-4.75);AT-II组去甲肾上腺素中位剂量为1.33 mg(Q1-Q3,0.78-2.04),AT-II中位剂量为0.34 mg(Q1-Q3,0.29-0.78)。
临床怎么用
- 对于心脏术后出现血管麻痹和高Δ-肾素水平的患者,可考虑使用AT-II以降低肾素水平并减少去甲肾上腺素用量。
局限性
- 回顾性设计,样本量较小(40例),可能存在选择偏倚和混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hyperreninemia after cardiac surgery is associated with cardiovascular instability. Angiotensin II (AT-II) could potentially attenuate hyperreninemia while maintaining target blood pressure. This study assesses the association between AT-II usage and renin levels in cardiac surgery patients with postoperative hyperreninemia and vasoplegia. METHODS: Between September 2020 and March 2021, we retrospectively identified 40 cardiac surgery patients with high Δ-renin levels (4 hours after cardiopulmonary bypass [CPB] minus preoperative levels) (defined as higher than 3.7 µU/mL) and vasopressor use who received a vasopressor therapy with either AT-II or continued norepinephrine alone. The primary outcome was the renin plasma level at 12 hours after surgery, adjusted by the renin plasma level at 4 hours after surgery. RESULTS: Overall, the median renin plasma concentration increased from a baseline with median of 44.3 µU/mL (Q1-Q3, 14.6-155.5) to 188.6 µU/mL (Q1-Q3, 29.8-379.0) 4 hours after CPB. High Δ-renin (difference between postoperation and preoperation) patients (higher than 3.7 µU/mL) were then treated with norepinephrine alone (median dose of 3.25 mg [Q1-Q3, 1.00-4.75]) or with additional AT-II (norepinephrine dose: 1.33 mg [Q1-Q3, 0.78-2.04]; AT-II dose: 0.34 mg [Q1-Q3, 0.29-0.78]). At 12 hours after surgery, AT-II patients had lower renin levels than standard of care patients (71.7 µU/mL [Q1-Q3, 21.9-211.4] vs 130.6 µU/mL [Q1-Q3, 62.9-317.0]; P = .034 adjusting for the renin plasma level at 4 hours after surgery). CONCLUSIONS: In cardiac surgery patients with hypotonia and postoperative high Δ-renin levels, AT-II was associated with reduced renin plasma levels for at 12 hours and significantly decreased norepinephrine use, while norepinephrine alone was associated with increased renin levels. Further studies of AT-II in cardiac surgery appear justified.
引用
- Meersch M, Weiss R, Massoth C, et al. The Association Between Angiotensin II and Renin Kinetics in Patients After Cardiac Surgery. Anesth Analg. 2022. PMID: 35171852. doi:10.1213/ANE.0000000000005953
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。